Tony Ho

Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA.

The Johns Hopkins Hospital, Inc. provides healthcare services. The hospital is affiliated to the Johns Hopkins University School of Medicine. It offers inpatient and outpatient health services that include general medicine, emergency and trauma care, pediatrics, maternity, and senior care. The company was founded in 1889 and is headquartered in Baltimore, MD.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.

Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then.